Tarik Regad

3.0k total citations
31 papers, 2.3k citations indexed

About

Tarik Regad is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Tarik Regad has authored 31 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 12 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Tarik Regad's work include Retinoids in leukemia and cellular processes (7 papers), interferon and immune responses (6 papers) and MicroRNA in disease regulation (6 papers). Tarik Regad is often cited by papers focused on Retinoids in leukemia and cellular processes (7 papers), interferon and immune responses (6 papers) and MicroRNA in disease regulation (6 papers). Tarik Regad collaborates with scholars based in United Kingdom, Italy and United States. Tarik Regad's co-authors include Mounira K. Chelbi‐Alix, Joshua R. D. Pearson, Vincenzo Desiderio, Virginia Tirino, Federica Papaccio, Gianpaolo Papaccio, Francesca Paino, Marco Bocchetti, Michele Caraglia and Angela Lombardi and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and Nature Neuroscience.

In The Last Decade

Tarik Regad

30 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tarik Regad United Kingdom 21 1.4k 551 538 432 260 31 2.3k
Mihai Gagea United States 27 1.6k 1.2× 784 1.4× 506 0.9× 363 0.8× 208 0.8× 62 2.4k
Laurent Vallar Luxembourg 27 1.4k 1.0× 809 1.5× 368 0.7× 378 0.9× 239 0.9× 60 2.4k
Ulrich Maurer Germany 26 2.4k 1.7× 407 0.7× 813 1.5× 707 1.6× 456 1.8× 43 3.4k
Marie‐Luise Kruse Germany 26 1.3k 1.0× 403 0.7× 741 1.4× 461 1.1× 179 0.7× 47 2.4k
Barbara Majello Italy 32 2.7k 1.9× 408 0.7× 557 1.0× 403 0.9× 245 0.9× 77 3.3k
Daekwan Seo South Korea 30 1.4k 1.0× 532 1.0× 645 1.2× 343 0.8× 356 1.4× 46 2.6k
John Inge Johnsen Sweden 41 2.2k 1.6× 1.0k 1.8× 1.2k 2.2× 577 1.3× 442 1.7× 111 4.1k
Ruth W. Craig United States 29 2.3k 1.7× 452 0.8× 965 1.8× 734 1.7× 247 0.9× 44 3.3k
Jean‐Baptiste Telliez United States 28 1.2k 0.9× 232 0.4× 807 1.5× 763 1.8× 233 0.9× 36 2.9k

Countries citing papers authored by Tarik Regad

Since Specialization
Citations

This map shows the geographic impact of Tarik Regad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarik Regad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarik Regad more than expected).

Fields of papers citing papers by Tarik Regad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tarik Regad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarik Regad. The network helps show where Tarik Regad may publish in the future.

Co-authorship network of co-authors of Tarik Regad

This figure shows the co-authorship network connecting the top 25 collaborators of Tarik Regad. A scholar is included among the top collaborators of Tarik Regad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tarik Regad. Tarik Regad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bocchetti, Marco, Alessia Maria Cossu, Manuela Porru, et al.. (2025). MiR-423-5p is a metabolic and growth tuner in hepatocellular carcinoma via MALAT-1 and mitochondrial interaction. Journal of Experimental & Clinical Cancer Research. 44(1). 270–270.
2.
Luce, Amalia, Angela Lombardi, Silvia Zappavigna, et al.. (2022). A Proteomic Approach Reveals That miR-423-5p Modulates Glucidic and Amino Acid Metabolism in Prostate Cancer Cells. International Journal of Molecular Sciences. 24(1). 617–617. 11 indexed citations
3.
Bocchetti, Marco, Silvia Zappavigna, Sarah Wagner, et al.. (2022). MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer. Journal of Experimental & Clinical Cancer Research. 41(1). 20–20. 43 indexed citations
4.
Schwerdtfeger, Melanie, Vincenzo Desiderio, Sebastian Kobold, et al.. (2021). Long non-coding RNAs in cancer stem cells. Translational Oncology. 14(8). 101134–101134. 35 indexed citations
5.
Vadakekolathu, Jayakumar, Catherine Johnson, Anne Schneider, et al.. (2020). Correction: MTSS1 and SCAMP1 cooperate to prevent invasion in breast cancer. Cell Death and Disease. 11(3). 205–205. 1 indexed citations
6.
Mele, Luigi, Vitale Del Vecchio, Francesco Marampon, et al.. (2020). β2-AR blockade potentiates MEK1/2 inhibitor effect on HNSCC by regulating the Nrf2-mediated defense mechanism. Cell Death and Disease. 11(10). 850–850. 23 indexed citations
7.
Mele, Luigi, Marcella La Noce, Francesca Paino, et al.. (2019). Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation. Journal of Experimental & Clinical Cancer Research. 38(1). 160–160. 91 indexed citations
8.
Vadakekolathu, Jayakumar, Sarah Wagner, Joshua R. D. Pearson, et al.. (2019). PYK2 promotes HER2-positive breast cancer invasion. Journal of Experimental & Clinical Cancer Research. 38(1). 210–210. 20 indexed citations
9.
Noce, Marcella La, Francesca Paino, Luigi Mele, et al.. (2018). HDAC2 depletion promotes osteosarcoma’s stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy. Journal of Experimental & Clinical Cancer Research. 37(1). 296–296. 62 indexed citations
10.
Mele, Luigi, Francesca Paino, Federica Papaccio, et al.. (2018). A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo. Cell Death and Disease. 9(5). 572–572. 160 indexed citations
11.
Vadakekolathu, Jayakumar, Catherine Johnson, Anne Schneider, et al.. (2018). MTSS1 and SCAMP1 cooperate to prevent invasion in breast cancer. Cell Death and Disease. 9(3). 344–344. 29 indexed citations
12.
13.
Reeder, Stephen, et al.. (2017). Identification and Isolation of Cancer Stem Cells Using NANOG-EGFP Reporter System. Methods in molecular biology. 1692. 139–148. 8 indexed citations
14.
Miles, Amanda K., Catherine Johnson, David J. Boocock, et al.. (2015). Cytoplasmic PML promotes TGF-β-associated epithelial–mesenchymal transition and invasion in prostate cancer. Oncogene. 35(26). 3465–3475. 48 indexed citations
15.
Miles, Amanda K., et al.. (2014). The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1. Cell Death and Disease. 5(2). e1061–e1061. 16 indexed citations
16.
Linley, Adam J., et al.. (2012). The Helicase HAGE Expressed by Malignant Melanoma-Initiating Cells Is Required for Tumor Cell Proliferation in Vivo. Journal of Biological Chemistry. 287(17). 13633–13643. 30 indexed citations
17.
Regad, Tarik, et al.. (2007). The neural progenitor-specifying activity of FoxG1 is antagonistically regulated by CKI and FGF. Nature Cell Biology. 9(5). 531–540. 79 indexed citations
18.
Blondel, Danielle, Tarik Regad, Benjamin Pavie, et al.. (2002). Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies. Oncogene. 21(52). 7957–7970. 131 indexed citations
19.
Regad, Tarik & Mounira K. Chelbi‐Alix. (2001). Role and fate of PML nuclear bodies in response to interferon and viral infections. Oncogene. 20(49). 7274–7286. 226 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mihai Gagea Breakdown of academic impact, for papers by Laurent Vallar Breakdown of academic impact, for papers by Ulrich Maurer Breakdown of academic impact, for papers by Marie‐Luise Kruse Breakdown of academic impact, for papers by Barbara Majello Breakdown of academic impact, for papers by Daekwan Seo Breakdown of academic impact, for papers by John Inge Johnsen Breakdown of academic impact, for papers by Ruth W. Craig Breakdown of academic impact, for papers by Jean‐Baptiste Telliez
Rankless by CCL
2026